Publications by authors named "Hans Huber"

Claim this Profile
I
Impact of Patient-Reported Outcome Monitoring via Recovery Tracker on Post-Discharge Outcomes After Colorectal Surgery: A Comparative Analysis Before and After Implementation.
Hans M Huber, Iris H Wei, Mohammad Ali Abbass, Georgios Karagkounis, Maria Widmar

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure.
Ayumi E Pottenger, Debashish Roy, Selvi Srinivasan, Thomas E J Chavas, Vladmir Vlaskin, Hans E Huber

Sci Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of percentage of ideal body weight on outcomes in ileo-anal pull through for ulcerative colitis.
Hans M Huber, Gary Slater, Tomas Heimann, Venu Bangla

Int J Colorectal Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slow and Steady Wins the Race: A Solid Case for a 3-Stage Approach in Ulcerative Colitis.
Michael C Plietz, Maia Kayal, Anam Rizvi, Venu G Bangla, Prerna Khetan, Hans M Huber

Dis Colon Rectum· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure.
Selvi Srinivasan, Debashish Roy, Thomas E J Chavas, Vladimir Vlaskin, Duy-Khiet Ho, Hans E Huber

J Control Release· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Debashis Sarker, Ruth Plummer, Tim Meyer, Mikael H Sodergren, Bristi Basu, Hans E Huber

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diode-pumped cw Alexandrite laser with temporally stable 6.5 W in TEM operation with prospect of power scaling.
Martin Walochnik, Bernd Jungbluth, Hans Huber, Jana Ammersbach, Alexander Munk

Opt Express· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Vikash Reebye, Kai-Wen Huang, Vivian Lin, Sheba Jarvis, Pedro Cutilas, Hans Huber

Oncogene· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Tamar Kinaciyan, Birgit Nagl, Sandra Faustmann, Florian Frommlet, Stephan Kopp, Hans Huber

J Allergy Clin Immunol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Jon Voutila, Vikash Reebye, Thomas C Roberts, Pantelitsa Protopapa, Pinelopi Andrikakou, Hans Huber

Mol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
Milena Weber, Katarzyna Niespodziana, Birgit Linhart, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients.
Raffaela Campana, Katharina Moritz, Angela Neubauer, Hans Huber, Rainer Henning

Sci Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy.
Christian Lupinek, Kurt Derfler, Silvia Lee, Thomas Prikoszovich, Oliver Movadat, Hans Huber

EBioMedicine· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
Petra Zieglmayer, Margarete Focke-Tejkl, René Schmutz, Patrick Lemell, René Zieglmayer, Hans Huber

EBioMedicine· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
Raffaela Campana, Katharina Moritz, Katharina Marth, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Margarete Focke-Tejkl, Milena Weber, Katarzyna Niespodziana, Angela Neubauer, Hans Huber

J Allergy Clin Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.
Laurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, Neil Rigby, Serge A Versteeg

Int Arch Allergy Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant house dust mite allergens.
Susanne Vrtala, Hans Huber, Wayne R Thomas

Methods· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy.
Dagmar Kollmann, Marija Geroldinger-Simic, Tamar Kinaciyan, Hans Huber, Christof Ebner

J Allergy Clin Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Marija Geroldinger-Simic, Tamar Kinaciyan, Birgit Nagl, Ursula Baumgartner-Durchschlag, Hans Huber

J Allergy Clin Immunol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.
Laurian Zuidmeer-Jongejan, Montserrat Fernandez-Rivas, Lars K Poulsen, Angela Neubauer, Juan Asturias, Hans Huber

Clin Transl Allergy· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.
Ningyan Zhang, Liming Liu, Calin Dan Dumitru, Nga Rewa Houston Cummings, Michael Cukan, Hans E Huber

MAbs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant allergens: what does the future hold?
Rudolf Valenta, Katarzyna Niespodziana, Margit Focke-Tejkl, Katharina Marth, Hans Huber

J Allergy Clin Immunol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hybrid simulation in nursing education. Between "hightec" and "hightouch"].
Claudia Schlegel, Hans Ruedi Huber

Krankenpfl Soins Infirm· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
Miguel Aste-Amézaga, Ningyan Zhang, Janet E Lineberger, Beth A Arnold, Timothy J Toner, Hans E Huber

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis